Federal Register / Vol. 86, No. 130 / Monday, July 12, 2021 / Notices 36549 

Item No. Bureau Subject 

4 ...................... INTERNATIONAL ..................................... TITLE: Mandatory Electronic Filing of Section 325(c) Applications, International 

Broadcast Applications, and Dominant Carrier Section 63.10(c) Quarterly Reports (IB Docket No. 21–265). 

SUMMARY: The Commission will consider an Order that would amend rules to require the remaining applications and reports to be filed electronically in the International Bureau Filing System (IBFS) and eliminate duplicative paper filing requirements. 

5 ...................... ENFORCEMENT ...................................... TITLE: Enforcement Bureau Action. 

SUMMARY: The Commission will consider an enforcement action. 

6 ...................... WIRELESS TELE-COMMUNICATIONS .. TITLE: Promoting Technological Solutions to Combat Contraband Wireless Device 

Use in Correctional Facilities (GN Docket No. 13–111). 

SUMMARY: The Commission will consider a Second Report and Order taking 

steps to combat contraband wireless devices in correctional facilities and Second Further Notice of Proposed Rulemaking seeking comment on additional 

technological solutions to combat contraband device usage in correctional facilities. 

* * * * * 

The meeting will be webcast with 

open captioning at: www.fcc.gov/live. 

Open captioning will be provided as 

well as a text only version on the FCC 

website. Other reasonable 

accommodations for people with 

disabilities are available upon request. 

In your request, include a description of 

the accommodation you will need and 

a way we can contact you if we need 

more information. Last minute requests 

will be accepted but may be impossible 

to fill. Send an email to: fcc504@fcc.gov 

or call the Consumer & Governmental 

Affairs Bureau at 202–418–0530. 

Additional information concerning 

this meeting may be obtained from the 

Office of Media Relations, (202) 418– 

0500. Audio/Video coverage of the 

meeting will be broadcast live with 

open captioning over the internet from 

the FCC Live web page at www.fcc.gov/ 

live. 

Federal Communications Commission. 

Marlene Dortch, 

Secretary. 

[FR Doc. 2021–14723 Filed 7–9–21; 8:45 am] 

BILLING CODE 6712–01–P 

FEDERAL ELECTION COMMISSION 

Sunshine Act Meeting 

TIME AND DATE: Thursday, July 15, 2021 

at 10:00 a.m. 

PLACE: Virtual meeting. Note: because 

of the covid-19 pandemic, we will 

conduct the open meeting virtually. If 

you would like to access the meeting, 

see the instructions below. 

STATUS: This meeting will be open to 

the public. To access the virtual 

meeting, go to the commission’s website 

www.fec.gov and click on the banner to 

be taken to the meeting page. 

MATTERS TO BE CONSIDERED: 

Draft Advisory Opinion 2021–06: 

Representative Robin Kelly and the 

Democratic Party of Illinois 

Draft Advisory Opinion 2021–07: PAC 

Management Services LLC 

(‘‘PACMS’’) 

Management and Administrative 

Matters 

CONTACT PERSON FOR MORE INFORMATION: 

Judith Ingram, Press Officer, Telephone: 

(202) 694–1220. 

Authority: Government in the Sunshine 

Act, 5 U.S.C. 552b. 

Laura E. Sinram, 

Acting Secretary and Clerk of the 

Commission. 

[FR Doc. 2021–14899 Filed 7–8–21; 4:15 pm] 

BILLING CODE 6715–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Solicitation of Nominations for 

Appointment to the CDC/HRSA 

Advisory Committee on HIV, Viral 

Hepatitis and STD Prevention and 

Treatment (CHACHSPT) 

ACTION: Notice. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC) is seeking 

nominations for membership on the 

CDC/HRSA Advisory Committee on 

HIV, Viral Hepatitis and STD Prevention 

and Treatment (CHACHSPT). The 

CHACHSPT consists of 18 experts in 

fields associated with public health; 

epidemiology; laboratory practice; 

immunology; infectious diseases; drug 

abuse; behavioral science; health 

education; healthcare delivery; state 

health programs; clinical care; 

preventive health; medical education; 

health services and clinical research; 

and healthcare financing, who are 

selected by the Secretary of the U.S. 

Department of Health and Human 

Services (HHS). 

DATES: Nominations for membership on 

the CHACHSPT must be received no 

later than August 31, 2021. Packages 

received after this time will not be 

considered for the current membership 

cycle. 

ADDRESSES: All nominations should be 

electronically mailed to nchhstppolicy@

cdc.gov. 

FOR FURTHER INFORMATION CONTACT: 

Staci Morris, M.S., Committee 

Management Specialist, National Center 

for HIV/AIDS, Viral Hepatitis, STD, and 

TB Prevention, CDC, Atlanta, Georgia 

30329–4027; Telephone: (404) 718– 

7479; nchhstppolicy@cdc.gov. 

SUPPLEMENTARY INFORMATION: The 

Secretary of HHS, and by delegation, the 

CDC Director and the HRSA 

Administrator, are authorized by the 

PHS Act to: (1) Conduct, encourage, 

cooperate with, and assist other 

appropriate public health authorities, 

scientific institutions, and scientists in 

the conduct of research, investigations, 

experiments, demonstrations, and 

studies related to the cases, diagnosis, 

treatment, control, and prevention of 

physical and mental diseases, and other 

impairments; (2) assist states and their 

political subdivisions in preventing, 

suppressing, and treating communicable 

diseases and other preventable 

conditions and in promoting health and 

well-being; (3) assist public and nonprofit private entities in preventing, 

controlling and treating sexually 

transmitted diseases (STDs), including 

the Human Immunodeficiency Virus 

(HIV); (4) improve health and achieve 

health equity through access to quality 

services and a skilled health workforce 

and innovative programs; (5) support 

healthcare services to persons living 

with or at risk for HIV, viral hepatitis, 


khammond on DSKJM1Z7X2PROD with NOTICES
36550 Federal Register / Vol. 86, No. 130 / Monday, July 12, 2021 / Notices 

and other STDs; and (6) advance the 

education of health professionals and 

the public from HIV, viral hepatitis, and 

other STDs. 

The CDC/HRSA Advisory Committee 

on HIV and STD Prevention and 

Treatment meets at least two times each 

calendar year, or at the discretion of the 

Designated Federal Officer in 

consultation with the CHACHSPT cochairs. 

The CDC/HRSA Advisory Committee 

on HIV and STD Prevention and 

Treatment shall advise the Director, 

CDC, and the Administrator, HRSA, 

regarding objectives, strategies, policies, 

and priorities for HIV, viral hepatitis, 

and other STD prevention and treatment 

efforts, including surveillance of HIV 

infection, Acquired Immunodeficiency 

Syndrome (AIDS), viral hepatitis, other 

STDs, and related behaviors; 

epidemiologic, behavioral, health 

services, and laboratory research on 

HIV, viral hepatitis, and other STDs; 

identification of policy issues related to 

HIV/viral hepatitis/STD professional 

education, patient healthcare delivery, 

and prevention services; agency policies 

about prevention of HIV, viral hepatitis 

and other STDs, treatment, healthcare 

delivery, and research and training; 

strategic issues influencing the ability of 

CDC and HRSA to fulfill their missions 

of providing prevention and treatment 

services; programmatic efforts to 

prevent and treat HIV, viral hepatitis, 

and other STDs; and support to the 

agencies in their development of 

responses to emerging health needs 

related to HIV, viral hepatitis and other 

STDs. 

Nominations are being sought for 

individuals who have expertise and 

qualifications necessary to contribute to 

the accomplishments of the committee’s 

objectives. Nominees will be selected 

based on expertise in the fields of public 

health; epidemiology; laboratory 

practice; immunology; infectious 

diseases; drug abuse; behavioral science; 

health education; healthcare delivery; 

state health programs; clinical care; 

preventive health; medical education; 

health services and clinical research; 

and healthcare financing. The 

Committee shall also include 

representation of persons with HIV and 

other affected populations; state and 

local health and education agencies; 

HIV/viral hepatitis/STD communitybased organizations; and the ethics or 

faith-based community. Federal 

employees will not be considered for 

membership. Members may be invited 

to serve for up to four-year terms. 

Selection of members is based on 

candidates’ qualifications to contribute 

to the accomplishment of CHACHSPT 

objectives. The U.S. Department of 

Health and Human Services policy 

stipulates that committee membership 

be balanced in terms of points of view 

represented, and the committee’s 

function. Appointments shall be made 

without discrimination on the basis of 

age, race, ethnicity, gender, sexual 

orientation, gender identity, HIV status, 

disability, and cultural, religious, or 

socioeconomic status. Nominees must 

be U.S. citizens, and cannot be full-time 

employees of the U.S. Government. 

Current participation on federal 

workgroups or prior experience serving 

on a federal advisory committee does 

not disqualify a candidate; however, 

HHS policy is to avoid excessive 

individual service on advisory 

committees and multiple committee 

memberships. Committee members are 

Special Government Employees (SGEs), 

requiring the filing of financial 

disclosure reports at the beginning and 

annually during their terms. Individuals 

who are selected for appointment will 

be required to provide detailed 

information regarding their financial 

interests and, for example, any work 

they do for the federal government 

through research grants or contracts. 

Disclosure of this information is 

required in order for CDC ethics officials 

to determine whether there is a conflict 

between the SGE’s public duties as 

members of CHACHSPT and their 

private interests, including an 

appearance of a loss of impartiality as 

defined by federal laws and regulations, 

and to identify any required remedial 

action needed to address the potential 

conflict. CDC reviews potential 

candidates for CHACHSPT membership 

when a vacancy arises and provides a 

slate of nominees for consideration to 

the Secretary of HHS for final selection. 

HHS notifies selected candidates of 

their appointment near the start of the 

term in December 1, 2021, or as soon as 

the HHS selection process has been 

completed. Note that the need for 

different expertise varies from year to 

year and a candidate who is not selected 

for an open position may be 

reconsidered for a subsequent open 

position. SGE nominees must be U.S. 

citizens, and cannot be full-time 

employees of the U.S. Government. 

Candidates should submit the following 

items: 

D Current curriculum vitae or resume, 

including complete contact information 

(telephone numbers, mailing address, 

email address). 

D At least one letter of 

recommendation from person(s) not 

employed by the U.S. Department of 

Health and Human Services. 

(Candidates may submit letters(s) 

from current HHS employees if they 

wish, but at least one letter must be 

submitted by a person not employed by 

an HHS agency (e.g., CDC, NIH, FDA, 

etc.). 

D A biographical sketch of the 

nominee (500 words or fewer). 

D A letter of interest or personal 

statement from the nominee stating how 

their expertise would inform the work 

of CHACHSPT. 

Nominations may be submitted 

directly by the individual seeking 

nomination or by the person/ 

organization recommending the 

candidate. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2021–14686 Filed 7–9–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–21–21GH; Docket No. CDC–2021– 

0065] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other Federal 

agencies the opportunity to comment on 

a proposed and/or continuing 

information collection, as required by 

the Paperwork Reduction Act of 1995. 

This notice invites comment on a 

proposed information collection project 

titled Using Real-time Prescription and 

Insurance Claims Data to Support the 

HIV Care Continuum. This proposed 

collection will collect data to evaluate 


khammond on DSKJM1Z7X2PROD with NOTICES